Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 226.00 | 266.00 | 0.8496 | 0.4956 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 349.00 | 266.00 | 1.3120 | 2.2461 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 312.50 | 180.33 | 291.00 | 266.00 | 1.0940 | 1.3475 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 312.50 | 180.33 | 274.00 | 266.00 | 1.0301 | 1.1085 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 188.00 | 266.00 | 0.7068 | 0.0771 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 312.50 | 180.33 | 172.00 | 266.00 | 0.6466 | -0.0809 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 202.00 | 266.00 | 0.7594 | 0.2243 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 200.00 | 266.00 | 0.7519 | 0.2027 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 191.00 | 266.00 | 0.7181 | 0.1079 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 245.00 | 266.00 | 0.9211 | 0.7272 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 312.50 | 180.33 | 254.00 | 266.00 | 0.9549 | 0.8420 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 263.00 | 266.00 | 0.9887 | 0.9600 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 243.00 | 266.00 | 0.9135 | 0.7021 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 312.50 | 180.33 | 207.00 | 266.00 | 0.7782 | 0.2788 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 397.00 | 266.00 | 1.4925 | 3.0847 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 312.50 | 180.33 | 245.00 | 266.00 | 0.9211 | 0.7272 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 293.00 | 266.00 | 1.1015 | 1.3763 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 180.33 | 254.00 | 266.00 | 0.9549 | 0.8420 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 312.50 | 180.33 | 357.00 | 266.00 | 1.3421 | 2.3800 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 312.50 | 180.33 | 439.00 | 266.00 | 1.6504 | 3.8870 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 312.50 | 180.33 | 329.00 | 266.00 | 1.2368 | 1.9218 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 312.50 | 180.33 | 159.00 | 266.00 | 0.5977 | -0.2011 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 312.50 | 180.33 | 368.00 | 266.00 | 1.3835 | 2.5679 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 315.00 | 266.00 | 1.1842 | 1.7038 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 312.50 | 180.33 | 201.00 | 266.00 | 0.7556 | 0.2135 |